Literature DB >> 26519745

Efficacy of the ND:YAG laser therapy on EBV and HSV1 contamination in periodontal pockets.

Francesco Saverio Martelli1, Giovanni Bacci2, Maria Laura Martelli1, Piero Nobili3, Anna Boddi1, Claudio Rosati1, Elena Fanti1.   

Abstract

AIM: The aim of this retrospective multicenter study was to verify the efficacy of Nd:YAG laser in the treatment of periodontal pockets infected by Epstein-Barr Virus (EBV) and Herpes Simplex Virus 1 (HSV1).
METHODS: Subgingival plaque samples of 291 Italian periodontal patients were analyzed by Real Time PCR to evaluate the frequency of both viruses before and after Nd:YAG laser-assisted periodontal treatment.
RESULTS: Before treatment, EBV and HSV1 were observed in 29.9% and in 3.8% of periodontal patients respectively, while co-infection with both viruses was detected in 1.7% of cases. Periodontal Nd:YAG laser treatment ("Periodontal Biological Laser-Assisted Therapy", PERIOBLAST) produced statistical significant benefits, especially in EBV periodontal infection: 78.2% of EBV positive patients became EBV-negative following treatment.
CONCLUSIONS: Results of this preliminary study highlight that EBV is found in periodontal pockets more frequently than HSV1, supporting the theory of the potential role of EBV in the onset and progression of periodontal disease. Moreover, our data showed that Nd:YAG laser-assisted periodontal treatment (Perioblast) is also effective in case of viral infection, validating evidences that it represents a successful alternative approach to traditional periodontal protocols.

Entities:  

Mesh:

Year:  2015        PMID: 26519745

Source DB:  PubMed          Journal:  Ig Sanita Pubbl        ISSN: 0019-1639


  2 in total

1.  Long-term efficacy of microbiology-driven periodontal laser-assisted therapy.

Authors:  F S Martelli; E Fanti; C Rosati; M Martelli; G Bacci; M L Martelli; E Medico
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-06       Impact factor: 3.267

2.  Epstein-Barr virus is associated with periodontal diseases: A meta-analysis based on 21 case-control studies.

Authors:  Zilong Gao; Juan Lv; Min Wang
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.